Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Ireland Ruling parties disagree on proposal to decriminalise personal drug use ...
  • Brazil Up to 0.3% THC in plants authorised for medical, pharmaceutical, industrial use ...
  • Australia Parliamentary committee makes suggestions for cannabis law in NSW ...
  • Australia Greens announce Parliament will vote on cannabis legalisation this month ...
  • Texas - United States Bills introduced in Senate and House on medical cannabis expansion ...
  • Texas - United States House bill introduced to regulate hemp production and require research permit ...
  • Texas - United States House bills introduced on legalising recreational cannabis ...
  • Lithuania - Ukraine Cannabis conference focuses on fibre hemp, addressing challenges, restrictions ...
  • Czech Republic Criminal law reform approved, will relax some cannabis-related laws ...
  • New Zealand First sublingual THC/CBD spray meets Medicinal Cannabis Agency quality standard ...
  • Poland Motion for cannabis decriminalisation presented to prime minister ...
  • Belgium Health Belgium updates notified herbal products for smoking list ...
View all
Regulatory reports

Luxembourg: CBD and cannabis regulation, July 2022

Written by || 20th July 2022 || Regulatory reports | Cannabinoids | Cannabis – medical | Cannabis – recreational | Regulation and legislation | GeographiesEurope Luxembourg

Hemp and CBD are not considered narcotics in Luxembourg, but there is little regulation of them. Luxembourg is likely to begin supplying its own cannabis for medical use after relying on imports since medical cannabis was legalised in 2018. The country might further relax its laws on cannabis if neighbouring Germany legalises it, but Luxembourg is currently not as cannabis-friendly as many thought it would be.

This report offers a detailed summary of the current regulatory framework in place for CBD, hemp and cannabis in Luxembourg. It covers everything from hemp cultivation and processing, to finished products and extracts, and the country’s medical and recreational cannabis policies.

Free Sample

Download a free sample page of the report

Luxembourg: CBD and cannabis regulation, July 2022

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Anthony Traurig

Senior advisor
Anthony is senior advisor to CannIntelligence, where he provides regulatory guidance on issues within the global cannabis sector. Having worked several years as a legal analyst at CannIntelligence, he continues to work on consultancy projects and contribute to regulatory products for the platform. Anthony has a BA in political science from North Carolina State University and a Juris Doctor from Charleston School of Law (South Carolina), and practised law for several years in the United States as a litigator.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.